Mutagenic Spectra Arising from Replication Bypass of the 2,6-Diamino-4-hydroxy-N5-methyl Formamidopyrimidine Adduct in Primate Cells
详细信息 查看全文
- 作者：Lauriel F. Earley ; Irina G. Minko ; Plamen P. Christov ; Carmelo J. Rizzo ; R. Stephen Lloyd
- 刊名：Chemical Research in Toxicology
- 出版年：2013
- 出版时间：July 15, 2013
- 年：2013
- 卷：26
- 期：7
- 页码：1108-1114
- 全文大小：233K
- 年卷期：v.26,no.7(July 15, 2013)
- ISSN：1520-5010
文摘
DNA exposures to electrophilic methylating agents that are commonly used during chemotherapeutic treatments cause diverse chemical modifications of nucleobases, with reaction at N7-dG being the most abundant. Although this base modification frequently results in destabilization of the glycosyl bond and spontaneous depurination, the adduct can react with hydroxide ion to yield a stable, ring-opened MeFapy-dG, and this lesion has been reported to persist in animal tissues. Results from prior in vitro replication bypass investigations of the MeFapy-dG adduct had revealed complex spectra of replication errors that differed depending on the identity of DNA polymerase and the local sequence context. In this study, a series of nine site-specifically modified MeFapy-dG-containing oligodeoxynucleotides were engineered into a shuttle vector and subjected to replication in primate cells. In all nine sequence contexts examined, MeFapy-dG was shown to be associated with a strong mutator phenotype, predominantly causing base substitutions, with G to T transversions being most common. Single and dinucleotide deletions were also found in a subset of the sequence contexts. Interestingly, single-nucleotide deletions occurred at not only the adducted site, but also one nucleotide downstream of the adduct. Standard models for primer-template misalignment could account for some but not all mutations observed. These data demonstrate that in addition to mutagenesis predicted from replication of DNAs containing O6-Me-dG and O4-Me-dT, the MeFapy-dG adduct likely contributes to mutagenic events following chemotherapeutic treatments.